ARTICLE | Distillery Therapeutics
PTEN mRNA nanoparticles increase sensitivity to cancer immunotherapy
July 29, 2021 10:40 PM UTC
DISEASE CATEGORY: Cancer
INDICATION: Melanoma; prostate cancer...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
DISEASE CATEGORY: Cancer
INDICATION: Melanoma; prostate cancer...